Shares of Bausch Health Companies (NYSE:BHC) are tumbling today, down 11.9% as of 3:20 p.m. EDT. The big drop resulted from the major stock market sell-off that was caused by continued worries about the global novel coronavirus outbreak and plunging oil prices.
It would be understandable for Bausch Health stock to tank if its business would be significantly affected by the coronavirus epidemic or by lower oil prices. But that's not the case.
Bausch Health makes the lion's share of its revenue from vision-care products and prescription drugs. How many customers are likely to quit wearing contacts because of the coronavirus? How many patients won't take Xifaxan for treating irritable bowel syndrome because oil prices are dirt cheap? The likely answer: zero.
There's no surprise that nearly every stock will drop on a day like today, given the major market indexes fell so sharply that trading had to be temporarily halted. But Bausch Health is one of the stocks that appear to have gotten swept up in the panic selling for no reason related to its actual business prospects.
That's not to say that Bausch Health is a great healthcare stock to buy right now. The company faces challenges, including sinking sales for several of its drugs due to loss of exclusivity. Bausch Health also has a huge debt load to service. There are plenty of reasons investors may want to avoid the stock -- but the coronavirus and plunging oil prices aren't among them.